Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes

NCT01272193 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

296

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin degludec/insulin aspart
DRUG: insulin glargine

Sponsor

Novo Nordisk A/S